Skip to Content

Edarbi

In the US, Edarbi (azilsartan medoxomil systemic) is a member of the drug class angiotensin receptor blockers and is used to treat High Blood Pressure.

US matches:

UK matches:

Ingredient matches for Edarbi

Azilsartan Medoxomil

Azilsartan kamedoxomil (a derivative of Azilsartan) is reported as an ingredient of Edarbi in the following countries:

  • Germany
  • Ireland
  • Mexico
  • Philippines
  • Spain
  • Switzerland
  • Thailand
  • United Kingdom

Azilsartan medoxomil (a derivative of Azilsartan) is reported as an ingredient of Edarbi in the following countries:

  • Bosnia & Herzegowina
  • Canada
  • Hong Kong
  • Lithuania
  • Poland
  • Portugal
  • Romania
  • Russian Federation
  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide